Clinical trial / 2006
Pomegranate juice supplementation did not improve clinical symptoms or biomarkers in stable COPD
In a double-blind trial, 30 patients with stable chronic obstructive pulmonary disease consumed 400 ml of pomegranate juice or placebo daily for five weeks. No differences were observed between groups for respiratory function, clinical symptoms, serobiochemical or hematological markers, or urinary isoprostane (p > 0.05). Pomegranate polyphenols were not detected intact in plasma or urine, yielding only non-antioxidant microbial metabolites.
- Study type
- Randomized controlled trial
- Who was studied
- 30 adults with stable chronic obstructive pulmonary disease
- What was measured
- Respiratory function, clinical symptoms, antioxidant status, urinary isoprostane, and polyphenol metabolites
THE PAPER
Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial.
Cerdá B, Soto C, Albaladejo MD, Martínez P, Sánchez-Gascón F, Tomás-Barberán F, Espín JC. Eur J Clin Nutr, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.